Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Transplantation and Cellular Therapy
|
July 23, 2022
Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force
Hannah-Lise T Schofield, Vanessa A Fabrizio, Suzanne Braniecki, et al.
Cancer
|
October 22, 2025
Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices
Susan K Parsons, Kathleen E Montgomery, Julienne Brackett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2017
Reply to I.J. Cohen
Kristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
Jeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Transplantation and Cellular Therapy
|
July 23, 2022
Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force
Hannah-Lise T Schofield, Vanessa A Fabrizio, Suzanne Braniecki, et al.
Cancer
|
October 22, 2025
Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices
Susan K Parsons, Kathleen E Montgomery, Julienne Brackett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2017
Reply to I.J. Cohen
Kristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
Jeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Page
of 1